Flow cytometric determination of allergen-specific T lymphocyte proliferation from whole blood in experimentally asthmatic cats.

The ability to quantify feline lymphocyte proliferation, especially to specific antigen or allergen, would be valuable in experimental models and naturally developing disease where activated lymphocytes drive immune responses. Traditional proliferation assays may pose radioactivity hazards, lack the ability to distinguish viable from non-viable cells, and cannot discriminate individual populations of proliferating lymphocytes (e.g., the CD4+ T cell class). We hypothesized that in an experimental model of feline allergic asthma a four-color flow cytometric assay capable of simultaneously detecting division, viability and cell surface markers (pan T cell marker CD5 or CD4) would allow characterization of lymphocytes stimulated ex vivo using the sensitizing allergen, Bermuda grass (BGA). Peripheral blood mononuclear cells were harvested from eight experimentally asthmatic cats to validate and optimize use of a cell proliferation dye or bromodeoxyuridine (BrdU) with BGA-specific stimulation in a lymphocyte proliferation flow cytometric assay. Only the latter reagent was suitable in the cat. After a 3 day incubation, antibodies with different fluorochromes were used to identify BrdU, viable cells, CD5 and CD4 for subsequent flow cytometric analysis. In asthmatic cats, the group mean ± SEM of proliferating CD5+ lymphocytes was 2.3 ± 0.5%. The group mean ± SEM of proliferating CD4+ lymphocytes was 1.2 ± 0.3%. Flow cytometry is a sensitive method for detecting simultaneous proliferation and viability of very minor populations of allergen-specific lymphocytes in experimentally asthmatic cats.

Influence of Ganoderma lucidum on blood biochemistry and immunocompetence in horses.

The characteristic ingredients of Ganoderma lucidum, such as polysaccharides, triterpenoids, nucleic acids and small proteins, have been found and proved to have many special pharmacological properties. Mice and rats have been extensively used to investigate the effects of G. lucidum. Experiments with horses as an animal model for investigating the effects of G. lucidum have never been reported. The purpose of this investigation was to understand the influence of G. lucidum feeding on blood biochemistry and immunocompetence in horses. Complete blood count (CBC) and blood biochemistry were surveyed routinely. Cellular-mediated immunity was monitored by flow cytometry to survey the percentage changes of CD5+, CD4+, CD8+ T-lymphocytes and B-lymphocytes in the peripheral blood lymphocytes (PBLs). The effect of G. lucidum on humoral immunity was experimented by fast plate agglutination test to survey the change and manifestation of the titer of specific anti-egg albumin antibodies in the serum after egg albumin injection. The findings on CBC and blood biochemistry indicated that G. lucidum was quite safe to horses. Experimental result on cell-mediated immunity showed that G. lucidum could increase the percentage of CD5+, CD4+ and CD8+ T-lymphocytes in PBLs (p < 0.001). Experimental result on humoral immunity showed that G. lucidum could help the horses to produce a significantly higher quantity of specific antibodies in a shorter time (p < 0.001).

CD5+ and CD5- B1-like lymphocytes in healthy guinea pig.

Spleen, lymph node, and peripheral blood lymphocytes from healthy guinea pigs (gp) were examined for their ability to produce polyreactive autoantibodies to a battery of self-antigens and to cryptic determinants (phosphatidylcholine) on bromelain-treated mouse red blood cells (Br-MRBC). The mouse monoclonal antibody (Mab) 8BE6 anti-gp pan-T (CD5) marker was used for identification of CD5+ B1 cells by the plaque-forming assay (PFC), immunofluorescence, complement-mediated cytotoxicity, and immunocytochemistry. The detection of CD5+ cells by the 8BE6 Mab depended on the method used. They were better demonstrated by cytolysis and immunocytochemistry than by FACS analysis. By the latter method, the level of the CD5+ B cell subpopulation was associated neither with the age of the gp nor with the organ examined. Similarly wide ranges of PFC were detected in untreated or LPS-treated animals regardless of age and organ. The vast majority of the LPS-stimulated IgM antibody-secreting B lymphocytes reacting with the Br-MRBC, and those producing natural autoantibodies, did not bind the 8BE6 Mab.